The in vitro fine particle dose with Symbicort Rapihaler pMDI is similar using either NebuChamber or AeroChamber Plus valved holding chamber spacer devices

F. Chambers, E. Berg, M. Brown, J. O. Svensson (Loughborough, United Kingdom; Lund, Sweden)

Source: Annual Congress 2005 - Asthma management IV
Session: Asthma management IV
Session type: Thematic Poster Session
Number: 3291
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Chambers, E. Berg, M. Brown, J. O. Svensson (Loughborough, United Kingdom; Lund, Sweden). The in vitro fine particle dose with Symbicort Rapihaler pMDI is similar using either NebuChamber or AeroChamber Plus valved holding chamber spacer devices. Eur Respir J 2005; 26: Suppl. 49, 3291

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
In vitro evaluation of spacers in comparison with T-adapters in mechanical ventilation with pressurized metered dose inhalers (pMDI) and vibrating mesh nebulizer.
Source: International Congress 2019 – COPD and other specific entities in intensive care unit medicine
Year: 2019

In vitro aerosol delivery by vibrating mesh nebulizer (VMN) and pressurized metered dose inhaler (pMDI) using spacers in comparison with T adapters in mechanical ventilation.
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020



In vitro comparison of aerosol characteristics of HFA albuterol (salbutamol) pressurized metered dose inhaler (pMDI) formulation from three valved holding chambers (VHCs)
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II
Year: 2011

In vitro comparison of aerosol characteristics of HFA ipratropium bromide pressurized metered dose inhaler (pMDI) formulation from three valved holding chambers (VHCs)
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I
Year: 2011

Assessment of the suitability of filters for use in clinical studies with an HFA fluticasone propionate pressurized metered dose inhaler (pMDI) and a valved holding chamber (VHC)
Source: Annual Congress 2011 - Lung function today and tomorrow II
Year: 2011

In vitro performance of a small non-electrostatic valved holding chamber made from metal with three different brands of pressurized metered dose inhalers
Source: Eur Respir J 2006; 28: Suppl. 50, 712s
Year: 2006

Impact of inhalation delay on medication delivery from a salbutamol HFA pressurized metered dose inhaler used with and without a new prototype portable valved holding chamber
Source: International Congress 2019 – COPD treatment: clinical trials, cohorts and inhaler device studies
Year: 2019

Valved holding chamber (VHC) angle can affect pressurized netered-dose inhaler (pMDI) medication delivery efficiency
Source: International Congress 2018 – Determinants and monitoring of asthma control
Year: 2018




A novel breath-actuated vortex spacer device increases respirable dose delivery of fluticasone/salmeterol in combination
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases II
Year: 2008


In vitro equivalence exists for infant non-conducting (NC) and anti-static (AS) valved holding chambers (VHC) from the same family of add on devices used with pressurized metered dose inhalers (pMDIs) provided pre-conditioning of the non-conducting VHCs is undertaken
Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I
Year: 2010


Effect of the actuator orifice diameter on the biodisposition of a new budesonide CFC-free metered dose inhaler formulation
Source: Eur Respir J 2001; 18: Suppl. 33, 102s
Year: 2001

Device handling study of a novel breath-actuated inhaler Synchrobreathe vs pMDI
Source: International Congress 2019 – COPD treatment: clinical trials, cohorts and inhaler device studies
Year: 2019

In vitro comparison of output and particle size distribution of budesonide from metered-dose inhaler with three spacer devices during pediatric tidal breathing
Source: Eur Respir J 2005; 26: Suppl. 49, 161s
Year: 2005

Comparison of proficiency of pressurized metered dose inhaler (pMDI) use with asthma control
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Year: 2008


Aerosol characterization of three corticosteroids in MDIs plus a new spacer device (Fluspacer®) vs MDIs alone
Source: Eur Respir J 2001; 18: Suppl. 33, 101s
Year: 2001

Pressurized Metered Dose Inhaler (pMDI) with holding chamber - Correct procedure
Source: Procedure Video 2018
Year: 2018

In vitro testing of an improved collapsible valved holding chamber (CHC) with a pressurized metered-dose inhaler delivered bronchodilator, simulating an adult mechanically ventilated patient
Source: Annual Congress 2010 - Treatment options for asthma
Year: 2010


In vitro comparison of Pulmicort Respules™ with Clenil® pro aerosol in combination with three nebulisers
Source: Eur Respir J 2002; 20: Suppl. 38, 41s
Year: 2002

Flutide™ Diskus™ less consistent than Pulmicort® Turbuhaler® with respect to in vitro fine particle dose proportionality
Source: Eur Respir J 2001; 18: Suppl. 33, 157s
Year: 2001

In vitro evaluation of a new spacer for pMDI and nebulizers in mechanical ventilation
Source: Annual Congress 2012 - Multidisciplinary critical care
Year: 2012